Hill J C, Sealy R, Shackleton D, Stannard C, Korrubel J, Hering E, Loxton C
Department of Ophthalmology, Groote Schuur Hospital.
Br J Ophthalmol. 1992 Feb;76(2):91-4. doi: 10.1136/bjo.76.2.91.
The use and development of iodine-125 plaque therapy for choroidal malignant melanoma are described. Since 1975 experience has led to changes in plaque design and insertion techniques. Twenty-one patients were irradiated with local episcleral iodine-125 plaques. Three patients required a second plaque for tumour recurrence. Four eyes were enucleated because of continued tumour growth and a further eye was removed because of glaucoma secondary to radiation retinopathy. Two patients (9.5%) died of metastases. The remaining 19 patients are alive and clinically clear of metastases, with a mean follow up time of 73.1 months (range 43-142 months).
本文描述了碘-125敷贴疗法在脉络膜恶性黑色素瘤治疗中的应用与发展。自1975年以来,经验促使敷贴器设计和植入技术发生了变化。21例患者接受了局部巩膜外碘-125敷贴器照射。3例患者因肿瘤复发需要第二次使用敷贴器。4只眼因肿瘤持续生长而被摘除,另有1只眼因放射性视网膜病变继发青光眼而被摘除。2例患者(9.5%)死于转移。其余19例患者存活,临床上无转移迹象,平均随访时间为73.1个月(范围43 - 142个月)。